for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

ビジネス

Vaccine-stock valuations are very optimistic: advisor

Summit Place Financial Advisors' Liz Miller warns investors that the vast majority of coronavirus vaccine compounds that make it to Phase 3 trials ill fail. She tells Reuters' Fred Katayama the valuations of a number of vaccine makers will come down.

最新のビデオ
世界のこぼれ話
スポーツ
テクノロジー

ビジネス

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up